Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration
-
Published:2024-07
Issue:
Volume:205
Page:107219
-
ISSN:1043-6618
-
Container-title:Pharmacological Research
-
language:en
-
Short-container-title:Pharmacological Research
Author:
Farrag Yousof,
Farrag Mariam,
Varela-García María,
Torrijos-Pulpón Carlos,
Capuozzo Maurizio,
Ottaiano Alessando,
Lago Francisca,
Mera Antonio,
Pino Jesus,
Gualillo OresteORCID
Reference101 articles.
1. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021;Ferreira;Lancet Rheuma,2023
2. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019;Cieza;Lancet,2020
3. Classification of intervertebral disc disease;Fenn;Front. Vet. Sci.,2020
4. Adipokines as targets in musculoskeletal immune and inflammatory diseases;González-Rodríguez;Drug Discov. Today,2022
5. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases;Abella;Biomarkers,2015